USE AND COMPOSITION FOR TREATING MYASTHENIA GRAVIS AND OTHER MYASTHENIC SYNDROMES

• 收藏
• 分享

专利权人:

DAS-MG; Inc.

发明人:

Kathleen E. Clarence-Smith

申请号：

US16697240

公开号：

US20200129481A1

申请日:

2019.11.27

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present invention describes the use of a 5HT3-antagonist, in combination with pyridostigmine, to facilitate the symptomatic treatment of mammalian subjects, and particularly humans, dogs, and cats, suffering from a myasthenic syndrome, notably myasthenia gravis, by providing a therapeutically effective pyridostigmine bromide daily dose without the typical adverse effects.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/